BMC Pharmacology and Toxicology Pharmacology

Multi-target antidiabetic therapy with voglibose, ubiquinone, and tempol: synergistic effects on liver and skeletal muscle in experimental type 2 diabetes

Öznur Tufan Akarslan, Dudu Erkoç Kaya, Muhammed Bahaeddin Dörtbudak, Büşra Kilinç, İbrahim Büyüktaşkapulu, Fatma Göktürk, Muhammed Demircioğlu, Ayşe Er, Burak Dik
Springer Nature · 2025-12-20 · DOI 10.1186/s40360-025-01071-2

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →